wwhite on PROD1PC65 with NOTICES

15188 Federal Register / Vol. 71, No. 58 / Monday, March 27, 2006 / Notices 

Dated: March 20, 2006. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 06–2934 Filed 3–24–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Decision to Evaluate a Petition to 

Designate a Class of Employees at 

Blockson Chemical Company, Joliet, 

Illinois, To Be Included in the Special 

Exposure Cohort 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice as 

required by 42 CFR 83.12(e) of a 

decision to evaluate a petition to 

designate a class of employees at the 

Blockson Chemical Company, in Joliet, 

Illinois, to be included in the Special 

Exposure Cohort under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. The 

initial proposed definition for the class 

being evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Blockson Chemical 

Company. 

Location: Building 55. 

Job Titles and/or Job Duties: Utility 

Engineer, Laborer, Research Chemist, 

Relief Operator, Plant Operator, 

Maintenance and Pipefitter, Lead Mixer, 

Operator, and Supervisor HF Acid. 

Period of Employment: October 10, 

1952 through December 31, 1962. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV. 

Dated: March 21, 2006. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health Centers for Disease Control 

and Prevention. 

[FR Doc. E6–4388 Filed 3–24–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA 225–06–8001] 

Memorandum of Understanding 

Between the Food and Drug 

Administration, Department of Health 

and Human Services, of the United 

States of America and the Certification 

and Accreditation Administration of 

the People’s Republic of China 

Covering Ceramicware Intended for 

Use in the Preparation, Serving or 

Storage of Food or Drink and Offered 

for Export to the United States of 

America 

AGENCY: Food and Drug Administration, 


HHS. 


ACTION: Notice. 


SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the Food 

and Drug Administration, Department of 

Health and Human Services, of the 

United States of America and the 

Certification and Accreditation 

Administration of the People’s Republic 

of China (CNCA). 

The purpose of this MOU is to 

establish a certification system that 

increases the likelihood that daily-use 

ceramicware manufactured in the 

People’s Republic of China (China) and 

offered for import into the United States 

complies with U.S. law. To that end, 

this MOU sets forth the criteria for 

certification of ceramicware to be 

exported directly from China to the 

United States and intended for use in 

the preparation, serving, or storage of 

food, and for certification of firms in 

China that are manufacturing such 

ceramicware. These certifications will 

enable FDA to reduce the frequency of 

its sampling of daily-use ceramicware 

from factories in China certified by 

CNCA/China Entry-Exit Inspection and 

Quarantine Bureaus (CIQs) and offered 

for import into the United States, in 

accordance with FDA’s confidence in 

the effectiveness of the CNCA/CIQ 

factory certification system. 

DATES: The agreement became effective 

January 26, 2006 (last signature date of 

the Chinese version of the MOU). 

FOR FURTHER INFORMATION CONTACT: 

Matthew E. Eckel, Office of 

International Programs (HFG–1), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville MD, 20857, 301–827– 

4480, FAX: 301–480–0716. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and understandings between FDA and 

others shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: March 17, 2006. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

BILLING CODE 4160–01–S